|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gao SP, Sun HF, Jiang HL, Li LD, Hu X, Xu
XE and Jin W: Loss of COX5B inhibits proliferation and promotes
senescence via mitochondrial dysfunction in breast cancer.
Oncotarget. 6:43363–43374. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li LD, Sun HF, Liu XX, Gao SP, Jiang HL,
Hu X and Jin W: Down-regulation of NDUFB9 promotes breast cancer
cell proliferation, metastasis by mediating mitochondrial
metabolism. PLoS One. 10:e01444412015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang HL, Sun HF, Gao SP, Li LD, Huang S,
Hu X, Liu S, Wu J, Shao ZM and Jin W: SSBP1 suppresses TGFβ-driven
epithelial-to-mesenchymal transition and metastasis in
triple-negative breast cancer by regulating mitochondrial
retrograde signaling. Cancer Res. 76:952–964. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiu YC, Li MY, Liu YH, Ding JY, Yu JY and
Wang TW: Foxp2 regulates neuronal differentiation and neuronal
subtype specification. Dev Neurobiol. 74:723–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsui D, Vessey JP, Tomita H, Kaplan DR and
Miller FD: FoxP2 regulates neurogenesis during embryonic cortical
development. J Neurosci. 33:244–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fisher SE and Scharff C: FOXP2 as a
molecular window into speech and language. Trends Genet.
25:166–177. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ostrow AZ, Kalhor R, Gan Y, Villwock SK,
Linke C, Barberis M, Chen L and Aparicio OM: Conserved forkhead
dimerization motif controls DNA replication timing and spatial
organization of chromosomes in S. cerevisiae. Proc Natl Acad Sci
USA. 114:E2411–E2419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jia WZ, Yu T, An Q, Yang H, Zhang Z, Liu X
and Xiao G: MicroRNA-190 regulates FOXP2 genes in human gastric
cancer. Onco Targets Ther. 9:3643–3651. 2016.PubMed/NCBI
|
|
10
|
Gascoyne DM, Spearman H, Lyne L, Puliyadi
R, Perez-Alcantara M, Coulton L, Fisher SE, Croucher PI and Banham
AH: The forkhead transcription factor FOXP2 is required for
regulation of p21WAF1/CIP1 in 143B osteosarcoma cell growth arrest.
PLoS One. 10:e01285132015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan X, Zhou H and Zhang T, Xu P, Zhang S,
Huang W, Yang L, Gu X, Ni R and Zhang T: Downregulation of FOXP2
promoter human hepatocellular carcinoma cell invasion. Tumour Biol.
36:9611–9619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang HL, Sun HF, Gao SP, Li LD, Hu X, Wu
J and Jin W: Loss of RAB1B promotes triple-negative breast cancer
metastasis by activating TGF-β/SMAD signaling. Oncotarget.
6:16352–16365. 2015.PubMed/NCBI
|
|
14
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ye X, Brabletz T, Kang Y, Longmore GD,
Nieto MA, Stanger BZ, Yang J and Weinberg RA: Upholding a role for
EMT in breast cancer metastasis. Nature. 547:E1–E3. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Strzyz P: Cancer biology: TGFβ and EMT as
double agents. Nat Rev Mol Cell Biol. 17:202–203. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta S and Maitra A: EMT: Matter of life
or death? Cell. 164:840–842. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Konopka G, Friedrich T, Davis-Turak J,
Winden K, Oldham MC, Gao F, Chen L, Wang GZ, Luo R, Preuss TM and
Geschwind DH: Human-specific transcriptional networks in the brain.
Neuron. 75:601–617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Newbury DF and Monaco AP: Genetic advances
in the study of speech and language disorders. Neuron. 68:309–320.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moustakas A and Heldin CH: Mechanisms of
TGFβ-induced epithelial-mesenchymal transition. J Clin Med. 5:pii:
E63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cohn A, Lahn MM, Williams KE, Cleverly AL,
Pitou C, Kadam SK, Farmen MW, Desaiah D, Raju R, Conkling P and
Richards D: A phase I dose-escalation study to a predefined dose of
a transforming growth factor-β1 monoclonal antibody (TβM1) in
patients with metastatic cancer. Int J Oncol. 45:2221–2231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cuiffo BG, Campagne A, Bell GW, Lembo A,
Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, et al:
MSC-regulated microRNAs converge on the transcription factor FOXP2
and promote breast cancer metastasis. Cell Stem Cell. 15:762–774.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cuiffo BG and Karnoub AE: Silencing FOXP2
in breast cancer cells promotes cancer stem cell traits and
metastasis. Mol Cell Oncol. 3:e10190222015. View Article : Google Scholar : PubMed/NCBI
|
